Social media and clinical trials: The pros and cons gain context when the patient is at the center
Social media is a useful tool for increasing awareness and disseminating information about clinical trials. However, risks include issues with confidentiality, privacy, and integrity of clinical trials.
Gespeichert in:
| Veröffentlicht in: | Cancer 2018-12, Vol.124 (24), p.4618-4621 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4621 |
|---|---|
| container_issue | 24 |
| container_start_page | 4618 |
| container_title | Cancer |
| container_volume | 124 |
| creator | Thompson, Michael A. O’Regan, Ruth M. |
| description | Social media is a useful tool for increasing awareness and disseminating information about clinical trials. However, risks include issues with confidentiality, privacy, and integrity of clinical trials. |
| doi_str_mv | 10.1002/cncr.31747 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2123712556</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2123712556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3937-c0aad00380bc5e136f2bca4922784268b27186e929c243ffdae923f30dd7ca433</originalsourceid><addsrcrecordid>eNp9kE1LwzAYx4Mobk4vfgAJeBGhMy9t03qT4hsMBZ3graRp6jK6dDYpc9_eZ-v04MFTnpcff578EDqlZEwJYVfKqnbMqQjFHhpSkoqA0JDtoyEhJAmikL8P0JFzc2gFi_ghGnDCecqSZIiK10YZWeOFLo3E0pZY1cYaBSPfwsJd4-lM42XbuH7bWIc_pLGbyusvj1czbbHfMNIbbT02QPrtREGr22N0UEGQPtm9I_R2dzvNHoLJ8_1jdjMJFE-5CBSRsiSEJ6RQkaY8rlihZJgyJpKQxUnBBE1inbJUsZBXVSmh5hUnZSmA43yELvpcOPaz087nC-OUrmtpddO5nFHGBWVRFAN6_gedN11r4TqgoiiNgRVAXfaUgt-7Vlf5sjUL2a5zSvKN-XxjPt-aB_hsF9kVIPMX_VENAO2Blan1-p-oPHvKXvrQb9iCjLM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2155962127</pqid></control><display><type>article</type><title>Social media and clinical trials: The pros and cons gain context when the patient is at the center</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Thompson, Michael A. ; O’Regan, Ruth M.</creator><creatorcontrib>Thompson, Michael A. ; O’Regan, Ruth M.</creatorcontrib><description>Social media is a useful tool for increasing awareness and disseminating information about clinical trials. However, risks include issues with confidentiality, privacy, and integrity of clinical trials.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.31747</identifier><identifier>PMID: 30339288</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Clinical trials ; Digital media ; Medical research ; Social networks</subject><ispartof>Cancer, 2018-12, Vol.124 (24), p.4618-4621</ispartof><rights>2018 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3937-c0aad00380bc5e136f2bca4922784268b27186e929c243ffdae923f30dd7ca433</citedby><cites>FETCH-LOGICAL-c3937-c0aad00380bc5e136f2bca4922784268b27186e929c243ffdae923f30dd7ca433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.31747$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.31747$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30339288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thompson, Michael A.</creatorcontrib><creatorcontrib>O’Regan, Ruth M.</creatorcontrib><title>Social media and clinical trials: The pros and cons gain context when the patient is at the center</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Social media is a useful tool for increasing awareness and disseminating information about clinical trials. However, risks include issues with confidentiality, privacy, and integrity of clinical trials.</description><subject>Clinical trials</subject><subject>Digital media</subject><subject>Medical research</subject><subject>Social networks</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LwzAYx4Mobk4vfgAJeBGhMy9t03qT4hsMBZ3graRp6jK6dDYpc9_eZ-v04MFTnpcff578EDqlZEwJYVfKqnbMqQjFHhpSkoqA0JDtoyEhJAmikL8P0JFzc2gFi_ghGnDCecqSZIiK10YZWeOFLo3E0pZY1cYaBSPfwsJd4-lM42XbuH7bWIc_pLGbyusvj1czbbHfMNIbbT02QPrtREGr22N0UEGQPtm9I_R2dzvNHoLJ8_1jdjMJFE-5CBSRsiSEJ6RQkaY8rlihZJgyJpKQxUnBBE1inbJUsZBXVSmh5hUnZSmA43yELvpcOPaz087nC-OUrmtpddO5nFHGBWVRFAN6_gedN11r4TqgoiiNgRVAXfaUgt-7Vlf5sjUL2a5zSvKN-XxjPt-aB_hsF9kVIPMX_VENAO2Blan1-p-oPHvKXvrQb9iCjLM</recordid><startdate>20181215</startdate><enddate>20181215</enddate><creator>Thompson, Michael A.</creator><creator>O’Regan, Ruth M.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20181215</creationdate><title>Social media and clinical trials: The pros and cons gain context when the patient is at the center</title><author>Thompson, Michael A. ; O’Regan, Ruth M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3937-c0aad00380bc5e136f2bca4922784268b27186e929c243ffdae923f30dd7ca433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Clinical trials</topic><topic>Digital media</topic><topic>Medical research</topic><topic>Social networks</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thompson, Michael A.</creatorcontrib><creatorcontrib>O’Regan, Ruth M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thompson, Michael A.</au><au>O’Regan, Ruth M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Social media and clinical trials: The pros and cons gain context when the patient is at the center</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2018-12-15</date><risdate>2018</risdate><volume>124</volume><issue>24</issue><spage>4618</spage><epage>4621</epage><pages>4618-4621</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Social media is a useful tool for increasing awareness and disseminating information about clinical trials. However, risks include issues with confidentiality, privacy, and integrity of clinical trials.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30339288</pmid><doi>10.1002/cncr.31747</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2018-12, Vol.124 (24), p.4618-4621 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2123712556 |
| source | Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Clinical trials Digital media Medical research Social networks |
| title | Social media and clinical trials: The pros and cons gain context when the patient is at the center |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A22%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Social%20media%20and%20clinical%20trials:%20The%20pros%20and%20cons%20gain%20context%20when%20the%20patient%20is%20at%20the%20center&rft.jtitle=Cancer&rft.au=Thompson,%20Michael%20A.&rft.date=2018-12-15&rft.volume=124&rft.issue=24&rft.spage=4618&rft.epage=4621&rft.pages=4618-4621&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.31747&rft_dat=%3Cproquest_cross%3E2123712556%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2155962127&rft_id=info:pmid/30339288&rfr_iscdi=true |